# TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

> **NCT03465644** · PHASE4 · COMPLETED · sponsor: **Duk-Woo Park, MD** · enrollment: 2018 (actual)

## Conditions studied

- Coronary Stenoses

## Interventions

- **DRUG:** Tailored antithrombotic strategy
- **DRUG:** Conventional antithrombotic strategy

## Key facts

- **NCT ID:** NCT03465644
- **Lead sponsor:** Duk-Woo Park, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-12
- **Primary completion:** 2025-02-13
- **Final completion:** 2025-02-13
- **Target enrollment:** 2018 (ACTUAL)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03465644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03465644, "TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03465644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*